Precision Fermentation-Derived Biomaterials Market Report 2026

Precision Fermentation-Derived Biomaterials Market Overview

• Precision Fermentation-Derived Biomaterials market size has reached to $0.6 billion in 2025 • Expected to grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 40.3% • Growth Driver: Increasing Preference For Animal-Free Products Fueling The Growth Of The Market Due To Rising Consumer Demand and Sustainable Alternatives • Market Trend: Technological Advancements In Precision Fermentation Bioreactors Enhance Production Efficiency And Support Sustainable Animal-Free Protein Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Precision Fermentation-Derived Biomaterials Market?

Precision fermentation-derived biomaterials are materials produced using engineered microorganisms through controlled fermentation processes to generate specific biological compounds such as proteins, enzymes, polymers, and other functional biomolecules. It integrates synthetic biology, metabolic engineering, and bioprocessing technologies to enable efficient, scalable, and sustainable production of bio-based materials. The main product types of precision fermentation-derived biomaterials include proteins, enzymes, lipids, polysaccharides, peptides and growth factors, and other biomolecules. Proteins refer to biologically synthesized functional macromolecules produced through engineered microbial fermentation processes for use across multiple industries. The different microbial hosts include yeast, bacteria, fungi, and algae. The distribution channels include direct sales, distributors, and contract manufacturing and the various applications involved are medical and healthcare, food and beverage, cosmetics and personal care, industrial and specialty materials, and agriculture and animal feed.

What Is The Precision Fermentation-Derived Biomaterials Market Growth Forecast?

The precision fermentation-derived biomaterials market size is expected to see exponential growth in the next few years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 40.3%. The growth in the forecast period can be attributed to increasing commercialization of precision fermentation products, rising demand for alternative proteins and enzymes, growing integration of automated bioprocessing systems, expansion of bio-manufacturing partnerships and collaborations, increasing focus on low-carbon material production. Major trends in the forecast period include scalable bio-based material production, increasing adoption of microbial fermentation platforms, development of animal-free biomaterials, expansion of high-purity functional biomolecule manufacturing, growing commercialization of next-generation bioprocessing technologies.

What Is The Driver Of The Precision Fermentation-Derived Biomaterials Market?

The increasing preference for animal-free products worldwide is expected to propel the growth of the precision fermentation-derived biomaterials market going forward. Animal-free products refer to plant-based, fermented, or cell-free alternatives developed without the use of animal-derived inputs. The rising preference for such products is driven by growing consumer awareness of health, sustainability, and ethical considerations, along with improved availability of high-quality alternatives. Precision fermentation-derived biomaterials play a critical role in this shift by providing scalable and sustainable ingredients that replicate the functionality of animal-derived components, facilitating the production of plant-based dairy, meat, and related products. For instance, in January 2025, according to Veganuary, a UK-based global organization, approximately 25. 8 million people worldwide participated in the Veganuary campaign, reflecting increasing adoption of vegan lifestyles. Therefore, the increasing preference for animal-free products is driving the growth of the precision fermentation-derived biomaterials industry.

Key Players In The Global Precision Fermentation-Derived Biomaterials Market

Major companies operating in the precision fermentation-derived biomaterials market are Evonik Industries AG, Novozymes A/S, Perfect Day Inc., Impossible Foods Inc., Standing Ovation SAS, The EVERY Company Inc., Formo Bio GmbH, Melt & Marble AB, TurtleTree Labs Pte. Ltd., Imagindairy Ltd., Eden Brew Pty Ltd., Onego Bio Ltd., Planet A Foods GmbH, Remilk Ltd., Verley GmbH, Vivici B.V., Change Foods Inc., De Novo Foodlabs Inc., Protera Bio SAS, Helaina Inc., Zero Cow Factory Pvt. Ltd., MeliBio Inc., Motif FoodWorks Inc., Shiru Inc., C16 Biosciences Inc., New Culture Inc., Better Dairy Ltd.

Global Precision Fermentation-Derived Biomaterials Market Trends and Insights

Major companies operating in the precision fermentation-derived biomaterials market are focusing on developing innovative solutions, such as precision-fermented functional dairy proteins, to meet the rising demand for animal-free, sustainable, and high-performance biomaterials. Precision fermentation utilizes engineered microorganisms to produce specific proteins and biomolecules without relying on animal sources, offering advantages such as reduced environmental impact, consistent quality, and scalable production compared to conventional methods. For instance, in March 2025, Vivici, a Netherlands-based precision fermentation ingredients company, launched Vivitein BLG, an animal-free beta-lactoglobulin (BLG) dairy protein, in the U. S. market. Produced through microbial fermentation, the ingredient delivers functional and nutritional properties comparable to traditional whey proteins and is suited for applications such as protein beverages, powders, and vegan-friendly nutrition products. Additionally, the product offers lower water usage and reduced carbon footprint compared to conventional dairy protein production, highlighting the role of precision fermentation in advancing sustainable and high-performance biomaterials.

What Are Latest Mergers And Acquisitions In The Precision Fermentation-Derived Biomaterials Market?

In May 2025, Amyris, Inc., a US-based biotechnology company, acquired full ownership of the RealSweet precision fermentation plant for an undisclosed amount. Through this acquisition, Amyris aims to strengthen its production capabilities for fermented ingredients using precision fermentation technology. The RealSweet precision fermentation plant is a Brazil-based facility that produces specialty biomaterials through industrial-scale precision fermentation, enabling scalable and sustainable production of high-quality ingredients.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Precision Fermentation-Derived Biomaterials Market Report 2026?

The precision fermentation-derived biomaterials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the precision fermentation-derived biomaterials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Precision Fermentation-Derived Biomaterials